Please login to the form below

Video: Immuno-oncology therapies


Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.

http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/

3rd June 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Guide
How to embrace behavioural science principles in healthcare MR
Research Partnership
Article
A glimmer of hope for Alzheimer’s patients, but at what cost?
Research Partnership
Video
Virtual Conference Live
Research Partnership
Report
Digital Health Tools - Physician Trends
Research Partnership
Webcast
Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership